PS
AstraZeneca Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Tagrisso (osimertinib) | EGFR-mutated lung cancer | Approved |
| Imfinzi (durvalumab) | Various cancers | Approved |
| Lynparza (olaparib) | BRCA-mutated cancers | Approved |
| Calquence (acalabrutinib) | Blood cancers | Approved |
| Farxiga (dapagliflozin) | Diabetes/Heart failure/CKD | Approved |
| Brilinta (ticagrelor) | Cardiovascular disease | Approved |
| Symbicort | Asthma/COPD | Approved |
| Breztri | COPD | Approved |